In addition, we found interactions among YWHAB, SOCS3, B2M, and CREM, suggesting that these genes may be important contributors to T-cell dysfunction and metabolic abnormalities and may serve as potential therapeutic targets for RA. The gene discussed is B2M; the disease is rheumatoid arthritis.